title: Spinal cord stimulation for long-term treatment of severe angina pectoris: what does the evidence say?
abstract: Patients who continue to suffer from severe and disabling angina pectoris, despite optimum treatment in terms of conventional pharmacological therapy and/or revascularization procedures, have been termed as having refractory angina pectoris. The future group of patients with refractory angina pectoris will be different from today's patients and represent a 'moving target' as risk factors, efficacy of treatment and indications continue to change. Spinal cord stimulation (SCS) is today considered as first-line treatment of refractory angina pectoris, by the European Society of Cardiology, with an anti-ischemic effect. There is strong evidence for SCS giving symptomatic benefits (decrease in anginal attacks), improved quality of life and improvement of functional status. In addition, SCS seems to be cost effective with a 'break-even' after approximately 15-16 months.
authors: Department of Acute & Cardiovascular Medicine, Multidisciplinary Pain Center, Pain Center, Sahlgrenska University Hospital/Ostra, Goteborg, 416 85, Sweden. mats.brjesson@telia.com
authors: Mats
authors: M
authors: Börjesson
authors: Paulin
authors: P
authors: Andréll
authors: Clas
authors: C
authors: Mannheimer
mesh_terms: D000787:Angina Pectoris / Q000503:physiopathology / Q000628:therapy*; D004599:Electric Stimulation Therapy / Q000379:methods*; D004562:Electrocardiography; D005500:Follow-Up Studies; D006801:Humans; D012720:Severity of Illness Index; D013116:Spinal Cord / Q000503:physiopathology*; D013997:Time Factors; D016896:Treatment Outcome